There is no significant association between the use of proton pump inhibitors (PPIs) and risk for cardiovascular events, a meta-analysis shows. However, patients with gastroesophageal reflux disease ...

Among patients receiving treatment for glioblastoma, PPI use is associated with worse progression-free and overall survival, a recent meta-analysis shows.

Although proton pump inhibitors may reduce heartburn and gastrointestinal bleeding in hospital patients, the therapy may also raise their mortality risk, according to a recent study published in the ...